Cargando…
Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma
BACKGROUND: Fibroblast growth factor 19 (FGF-19) is one of the founding members of the endocrine FGF subfamily. Recently, it has been the subject of much interest owing to its role in various physiological processes affecting glucose and lipid metabolism and the regulation of bile acid secretion as...
Autores principales: | Mohamed, Ghada Abdelrahman, Nashaat, Ehab Hasan, Fawzy, Hadeer Mohamed, ElGhandour, Ahmed Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055196/ https://www.ncbi.nlm.nih.gov/pubmed/35582295 http://dx.doi.org/10.4254/wjh.v14.i3.623 |
Ejemplares similares
-
Peripartum depression and its predictors: A longitudinal observational hospital-based study
por: Hamed, Sherifa Ahmed, et al.
Publicado: (2022) -
Evaluation of chronic idiopathic tinnitus and its psychosocial triggers
por: Hamed, Sherifa Ahmed, et al.
Publicado: (2023) -
Biliary complications in recipients of living donor liver transplantation: A single-centre study
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021) -
Impact of biliary complications on quality of life in live-donor liver transplant recipients
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021) -
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients
por: Alzamzamy, Ahmed, et al.
Publicado: (2021)